Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-10-16, Stock:PFE, The news for the past five days is as follows:
2018-10-09: NEWS1: How Artificial Intelligence Is Helping Pharmaceuticals Develop Drugs.NEWS2: How Artificial Intelligence Is Helping Pharmaceuticals Develop Drugs.NEWS3: Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?.NEWS4: Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?.NEWS5: [$$] Pfizer Prepares for CEO Transition With Executive Suite Changes.NEWS6: Health Care Sector Update for 10/09/2018: AFMD, ZIOP, JNJ, PFE, ABT, MRK, AMGN.NEWS7: Health Care Sector Update for 10/09/2018: AFMD, ZIOP, JNJ, PFE, ABT, MRK, AMGN.NEWS8: The Zacks Analyst Blog Highlights: Apple, Microsoft, Pfizer, Caterpillar and ConocoPhillips.NEWS9: The Zacks Analyst Blog Highlights: Apple, Microsoft, Pfizer, Caterpillar and ConocoPhillips.NEWS10: Pfizer Announces Executive Leadership Team.NEWS11: The Zacks Analyst Blog Highlights: Apple, Microsoft, Pfizer, Caterpillar and ConocoPhillips.NEWS12: Pfizer Announces New Executive Team - Quick Facts.NEWS13: Pfizer Announces New Executive Team - Quick Facts.NEWS14: Myriad Signs Commercialization Plan With Pfizer - Quick Facts.NEWS15: Myriad Signs Commercialization Plan With Pfizer - Quick Facts.
2018-10-10: NEWS1: Could Johnson & Johnson Meet Its Q3 2018 Sales Estimates?.NEWS2: Analysts’ Ratings for Johnson & Johnson before Its Q3 Earnings.NEWS3: Health Care Sector Update for 10/10/2018: NVCN,MYGN,PFE,IGC,AKRX.NEWS4: Health Care Sector Update for 10/10/2018: NVCN,MYGN,PFE,IGC,AKRX.NEWS5: Pfizer (PFE) Shares Cross 3% Yield Mark.NEWS6: Pfizer (PFE) Shares Cross 3% Yield Mark.NEWS7: Alexion Pharmaceuticals’ Operational Performance.NEWS8: Analyzing Alexion Pharmaceuticals’ Top-Line Trends.NEWS9: How Alexion Pharmaceuticals Is Positioned in October.NEWS10: Health Care Sector Update for 10/10/2018: MYGN,PFE,IGC,RARX,AKRX.NEWS11: Health Care Sector Update for 10/10/2018: MYGN,PFE,IGC,RARX,AKRX.NEWS12: Final trades: Verizon, EOG Resources, Arconic & Pfizer.NEWS13: J&J's Stelara Succeeds in Phase III Ulcerative Colitis Study.NEWS14: J&J's Stelara Succeeds in Phase III Ulcerative Colitis Study.NEWS15: How Bristol-Myers Squibb’s Valuation Metrics Look in October.NEWS16: MARKETS: Stocks at the Rubicon, as Intel leads the Dow lower, but Merck, Pfizer at 17-year highs.NEWS17: Myriad Genetics shares soar 7% on news it will conduct testing for Pfizer breast cancer treatment.NEWS18: Health Care Sector Update for 10/10/2018: IGC, AKRX, JNJ, PFE, ABT, MRK, AMGN.NEWS19: Health Care Sector Update for 10/10/2018: IGC, AKRX, JNJ, PFE, ABT, MRK, AMGN.NEWS20: What Bristol-Myers Squibb’s Operational Performance Indicates.NEWS21: Why Pfizer Stock Is Likely Seeing Big Buying.NEWS22: See what the IHS Markit Score report has to say about Pfizer Inc..NEWS23: The Daily Biotech Pulse: Novartis Blood Disorder Drug Improves Patient Outcomes, Audentes To Offer Shares.NEWS24: Myriad Genetics Inc. (MYGN) Is Climbing On Pfizer Deal.NEWS25: Myriad Genetics Inc. (MYGN) Is Climbing On Pfizer Deal.
2018-10-11: NEWS1: Pfizer To Pay $700,000 To Settle 'deceptive Advertising' Charges.NEWS2: Pfizer To Pay $700,000 To Settle 'deceptive Advertising' Charges.NEWS3: Stock Sell-Off Continues; VIX Hits 8-Month High.NEWS4: Stock Sell-Off Continues; VIX Hits 8-Month High.NEWS5: Why a Peninsula cancer fighter soared nearly 40% after record-breaking IPO.NEWS6: Market Close Report: NASDAQ Composite index closes at 7,329.06 down -92.99 points.NEWS7: Market Close Report: NASDAQ Composite index closes at 7,329.06 down -92.99 points.NEWS8: Wall Street Analysts See Upside Potential of 3.9% in TEVA.NEWS9: Pfizer settles New York probe into 'deceptive' copay coupons.NEWS10: Pfizer settles false advertising charges.NEWS11: Pfizer to pay $700,000 to settle &apos;deceptive advertising&apos; charges; stock drops to pace Dow losers.NEWS12: Dow Movers: PFE, NKE.NEWS13: Dow Movers: PFE, NKE.NEWS14: Molecular Diagnostic Market Gains Momentum: 3 Stocks in Focus.NEWS15: Molecular Diagnostic Market Gains Momentum: 3 Stocks in Focus.NEWS16: Company News For Oct 11, 2018.NEWS17: Molecular Diagnostic Market Gains Momentum: 3 Stocks in Focus.NEWS18: Health Care Sector Update for 10/11/2018: TRXC, SEM, BOLD, JNJ, PFE, ABT, MRK, AMGN.NEWS19: Health Care Sector Update for 10/11/2018: TRXC, SEM, BOLD, JNJ, PFE, ABT, MRK, AMGN.NEWS20: Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for October 12, 2018.NEWS21: Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for October 12, 2018.NEWS22: AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for October 12, 2018.NEWS23: AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for October 12, 2018.NEWS24: What to Expect from Johnson & Johnson’s Q3 2018 Earnings.NEWS25: How Analysts View Alexion Pharmaceuticals Stock in October.
2018-10-12: NEWS1: Winners and losers.NEWS2: Invest Like Warren Buffett with These Stocks & ETF.NEWS3: Invest Like Warren Buffett with These Stocks & ETF.NEWS4: Invest Like Warren Buffett with These Stocks & ETF.NEWS5: What Vertex Pharmaceuticals’ Valuation Trend Indicates.NEWS6: 3 Big Pharma Stocks Racing Along the Road to China.NEWS7: 3 Big Pharma Stocks Racing Along the Road to China.NEWS8: Why Pfizer’s Share Price Fell in the Last Two Days.NEWS9: 3 Big Pharma Stocks Racing Along the Road to China.NEWS10: Pfizer settles New York probe into 'deceptive' copay coupons.
2018-10-15: NEWS1: Invest Like Warren Buffett with These Stocks & ETF.NEWS2: Invest Like Warren Buffett with These Stocks & ETF.NEWS3: Trump&apos;s Drug-Ad Price Shaming Won&apos;t Fix the Problem.NEWS4: 3 Healthcare Stocks to Buy Amid the Carnage.NEWS5: 3 Healthcare Stocks to Buy Amid the Carnage.NEWS6: Drugmakers to disclose prices for medicines advertised on TV.NEWS7: Merck’s Operating Expenditure and Recent Developments.NEWS8: What’s Expected for Merck’s Q3 2018 Earnings.NEWS9: Merck Is Expected to Record Steady Revenue Growth in Q3.NEWS10: Dow Movers: PFE, JPM.NEWS11: Dow Movers: PFE, JPM.NEWS12: 3 Healthcare Stocks to Buy Amid the Carnage.NEWS13: Drugmakers will soon talk about price in ads — but not as explicitly as Trump administration wants.NEWS14: PFE or NVO: Which Is the Better Value Stock Right Now?.NEWS15: PFE or NVO: Which Is the Better Value Stock Right Now?.NEWS16: Health Care Sector Update for 10/15/2018: SNGX, TNDM, JNJ, PFE, ABT, MRK, AMGN.NEWS17: Health Care Sector Update for 10/15/2018: SNGX, TNDM, JNJ, PFE, ABT, MRK, AMGN.NEWS18: PFE or NVO: Which Is the Better Value Stock Right Now?.NEWS19: 2 Pharmaceutical Stocks to Buy With Dividends of 3% or Better.NEWS20: 2 Pharmaceutical Stocks to Buy With Dividends of 3% or Better.NEWS21: 2 Pharmaceutical Stocks to Buy With Dividends of 3% or Better.

Answer: Rise